On Thursday, China officially put forward Song Li as a candidate for the position of director-general of the World Health Organization (WHO). Song is a public health expert with a background in maternal and child health, reproductive health, international collaboration, and China’s handling of significant health crises, such as SARS, avian influenza, and COVID-19.
If selected, Song would take over from Tedros Adhanom Ghebreyesus, whose current five-year term concludes on August 15, 2027. Tedros, who began his second term in August 2022, is ineligible for a third term according to WHO regulations. The next director-general will be appointed at the World Health Assembly scheduled for May 2027, following a shortlist of up to three candidates prepared by the WHO Executive Board.
Song has dedicated a significant portion of her career to China’s health system, climbing the ranks within the maternal and child health administration. Her 2023 curriculum vitae, submitted when she was nominated for the regional director role for the WHO Western Pacific region, indicates that she earned her master’s degree in clinical medicine with a focus on gynecology and obstetrics at Shandong Medical University from 1997 to 2000.
She went on to achieve a PhD in public health from Peking University between 2006 and 2010 and spent six months as a visiting scholar at Harvard University in 2010, concentrating on global health.
Song’s career in health administration began in 2002 as a program officer in the women’s health division, where she eventually advanced to deputy director and then director of the division. In December 2015, she was appointed deputy director-general of the Department of Maternal and Child Health, and in March 2021, she became the director-general of that department, as noted in her WHO CV.
In October 2023, she took on the role of secretary of the All-China Women’s Federation, which is the official organization representing women in China. Maternal and child health has been a pivotal aspect of her career, and her 2023 WHO application highlighted over 21 years of experience in the sector, focusing on policy development, healthcare organization, and workforce training.
Her expertise includes areas such as midwifery, prenatal diagnostics, assisted reproductive technologies, and initiatives to prevent the transmission of HIV, syphilis, and hepatitis B from mothers to children. Additionally, she contributed to a program that provided delivery subsidies to rural pregnant women in China.
Song’s prominence grew during the COVID-19 pandemic, where she, as the deputy director of maternal and child health, outlined strategies to ensure maternal and newborn healthcare remained accessible during the crisis. She reported that treatment networks were created for pregnant women infected with COVID-19, and specific hospitals were designated for their care. Maternal and child health facilities were also directed to uphold triage and infection control while reinstating regular medical services.
Her official biography notes that she served as the editor-in-chief for a 2020 document that addressed COVID-19 prevention and control concerning maternal and child health, designed to provide national guidance during the pandemic.
Previously, in 2023, China had nominated Song for the role of regional director for the Western Pacific at the WHO, where she was one of five contenders but ultimately lost to Saia Ma’u Piukala from Tonga.
Song’s nomination is significant as the WHO faces various challenges, including financial constraints, discussions on institutional reform, and the ongoing repercussions of the COVID-19 pandemic. The political dynamics surrounding the organization have also shifted, particularly following the United States’ withdrawal from the WHO during Donald Trump’s presidency.
According to reports, China’s nomination of Song may allow Beijing to enhance its influence within the WHO at a time when U.S. engagement with the organization and broader UN system has diminished. Mao Ning, a spokesperson for the Chinese Foreign Ministry, stated that Song’s nomination reflects China’s commitment to multilateralism and aims to foster a global health community, asserting that she could help the WHO enhance its global health initiatives.
If elected, Song would be the second individual from China to lead the WHO, following Margaret Chan, who served as director-general from 2007 to 2017 before the onset of the COVID-19 pandemic and the notable decline in U.S.-China relations.
The election process for the WHO director-general commenced in April 2026, with member states invited to submit candidates by the September 24 deadline. The WHO is expected to announce the candidates following the conclusion of regional committee meetings, with the first candidates’ forum set for November 18. The Executive Board will review the candidates and nominate up to three individuals during its January 2027 session, with the final decision to be made by the World Health Assembly in May 2027 through a secret ballot.
Other known candidates include officials from Saudi Arabia, Belgium, Qatar, Botswana, Indonesia, and Spain.


















